Cardiac glycoside analogs in combination with emodin for cancer therapy
US8541382B2 · kind B2 · utility
2Cited by
11References
40Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 1, 2011 |
| Grant date | Sep 24, 2013 |
| Priority date | — |
| Expiry date | Feb 1, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method and medicine for treating leukemia or other cancer includes administering to a patient diagnosed with leukemia or other cancer a treatment regimen that includes periodic doses of a combination of emodin and digoxin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.